AI Diagnoses Lung Disease from CT Images as Accurately as Medical Specialists

Doctors have waited a long time for an early means of diagnosing idiopathic pulmonary fibrosis, a potentially fatal disease that can scar a person’s lungs. Except for drugs that can delay the disease’s progression, established therapies do not exist. Since doctors face many difficulties diagnosing the disease, they often have to request a specialist diagnosis. In addition, many of the diagnostic techniques, such as lung biopsy, are highly invasive. These investigative measures may exacerbate the disease, increasing a patient's risk of dying. Now, researchers have developed an artificial intelligence (AI) algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis. The algorithm makes its diagnosis based only on information from non-invasive examinations, including lung images and medical information collected during daily medical care.

In order to develop the new technology to diagnose idiopathic pulmonary fibrosis, researchers at Nagoya University (Nagoya, Japan) used AI to analyze medical data collected during normal care from patients undergoing interstitial pneumonia treatment. They found that their AI diagnosed idiopathic pulmonary fibrosis with a similar level of accuracy as a human specialist. Despite finding that their AI performed just as well as experts, the team stress that they do not see it as replacing medical professionals. Instead, they hope that specialists will use AI in medical treatment to ensure that they do not miss opportunities for early treatment. Its use would also avoid invasive procedures, such as lung biopsies, which could save lives.

“Idiopathic pulmonary fibrosis has a very poor prognosis among lung diseases,” said Taiki Furukawa, Assistant Professor of the Nagoya University Hospital. “It has been difficult to diagnose even for general respiratory physicians. The diagnostic AI developed in this study would allow any hospital to get a diagnosis equivalent to that of a specialist. For idiopathic pulmonary fibrosis, the developed diagnostic AI is useful as a screening tool, and may lead to personalized medicine by collaborating with medical specialists.”

Furukawa is excited about the possibilities: “The practical application of diagnostic AI and collaborative diagnosis with specialists may lead to a more accurate diagnosis and treatment. We expect it to revolutionize medical care.”

Related Links:
Nagoya University 

Visit expo >

Gold Supplier

Ultrasound System

FUTUS LE

New

Gold Supplier

Electrode Solution and Skin Prep

Signaspray

New

Web-Based DICOM Viewer

iQ-4VIEW

New

Mobile Imaging Table

medifa 8000 hybrid